Mounjaro 00002-2340

Generic: Tirzepatide

Product NDC

00002-2340

Manufacturer: Eli Lilly And Company
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 28, 2023
Listing Expires: December 31, 2027
Application: NDA215866

Need to source Mounjaro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Tirzepatide	10 mg/.5mL

Drug Class

Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]G-Protein-linked Receptor Interactions [MoA]

Packaging Options(1)

00002-2340-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0002-2340-01) / .5 mL in 1 VIAL, SINGLE-DOSE

View →